Five things for pharma marketers to know: Monday, July 16, 2018

Share this content:

(Above: MM&M Awards judging on June 25)

From Use of Relationship Marketing to Agency of the Year, MM&M has revealed the shortlist for the 2018 MM&M Awards, chosen during a rigorous process last month by industry experts.
Recognized as healthcare marketing's highest accolades, the MM&M Awards are scheduled for October 11 in New York City. (MM&M)


The FDA on Friday approved the first treatment for smallpox in case the virus is used in a terrorist attack. The disease was eradicated in 1980, but people born since then haven't been vaccinated. SIGA Technologies has delivered 2 million treatments of the drug, TPOXX, for stockpiling by the government. (Associated Press)


While partnering with Berkshire Hathaway and JP Morgan Chase on healthcare costs, Amazon could also improve wellness by improving the way people eat, according to experts. For one, the ecommerce giant and owner of Whole Foods could cut deals with healthcare providers and insurers to subsidize healthy food (CNBC).


The pharma industry has become a hot topic in the New Jersey Senate race between incumbent Sen. Bob Menendez (D-NJ) and former Celgene CEO Bob Hugin. A campaign ad is taking Hugin to task for allowing Celgene to raise drug prices. (STAT)


The FDA has issued a voluntary recall of drug products that contain valsartan, which is used to treat heart failure and high blood pressure, due to an impurity. However, the FDA said patients taking treatments with valsartan should continue to do so until they find a replacement. (FDA)

Share this content:
Scroll down to see the next article